Healthcare Industry News: Riegel
News Release - January 6, 2009
Court Rules in Favor of Medtronic in Fidelis Litigation
MINNEAPOLIS – January 6, 2009 – (HSMN NewsFeed) - Medtronic, Inc. (NYSE: MDT) reported that on Jan. 5, the United States District Court for the District of Minnesota dismissed with prejudice the Master Consolidated Complaint for Individuals and the Master Consolidated Complaint for Third-Party Payors relating to the multi-district litigation (MDL) involving Medtronic’s Sprint Fidelis defibrillator leads on grounds of federal preemption. The Court issued a companion order that each case in the MDL will be dismissed with prejudice unless an individual plaintiff can establish his or her case survives the Court’s preemption analysis based on claims different from those asserted in the master complaints.“We are pleased with the Court’s decision, which is consistent with the United States Supreme Court’s ruling in Riegel v. Medtronic last year, following a long line of circuit court decisions,” said Bill Hawkins, Medtronic’s chairman and chief executive officer. “This decision supports the principle that the U.S. Food and Drug Administration is the appropriate body to determine the safety and efficacy of innovative technologies.”
About Medtronic
Medtronic, Inc. (www.medtronic.com), headquartered in Minneapolis, is the global leader in medical technology -- alleviating pain, restoring health, and extending life for millions of people around the world.
Any forward-looking statements are subject to risks and uncertainties such as those described in Medtronic’s Annual Report on Form 10-K for the year ended April 25, 2008. Actual results may differ materially from anticipated results.
Source: Medtronic
Issuer of this News Release is solely responsible for its
content.
Please address inquiries directly to the issuing company.
Related News Items
Medtronic Announces FDA Clearance for LigaSure(TM) RAS Maryland Instrument on the Hugo(TM) RAS SystemMedtronic Announces Strategic Investments to Support Future Expansion of Cardiac Ablation Portfolio as Physician Demand for Affera(TM) Technologies Broadens
Medtronic Announces CE Mark for Stealth AXiS(TM) Surgical System
FindReps: Screen and connect with Medical Sales Rep candidates (Direct Reps and Independents) – anonymously, in real time.
RepJobs: Job Opportunities for Direct Sales Reps and New Product Lines for Independents!